Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
2 recherche sur le mot-clé 'Psychotropics'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Prevalence of Psychotropic Drug Use in Adults with Intellectual Disability: Positive and Negative Findings from a Large Scale Study / John A. TSIOURIS in Journal of Autism and Developmental Disorders, 43-3 (March 2013)
[article]
Titre : Prevalence of Psychotropic Drug Use in Adults with Intellectual Disability: Positive and Negative Findings from a Large Scale Study Type de document : Texte imprimé et/ou numérique Auteurs : John A. TSIOURIS, Auteur ; Soh-Yule KIM, Auteur ; W. Ted BROWN, Auteur ; Jill PETTINGER, Auteur ; Ira L. COHEN, Auteur Article en page(s) : p.719-731 Langues : Anglais (eng) Mots-clés : Psychotropics Intellectual disability Survey Diagnosis Challenging behavior Aggression Index. décimale : PER Périodiques Résumé : The use of psychotropics by categories and the reason for their prescription was investigated in a large scale study of 4,069 adults with ID, including those with autism spectrum disorder, in New York State. Similar to other studies it was found that 58 % (2,361/4,069) received one or more psychotropics. Six percent received typical, 6 % received typical, while 39 % received atypical antipsychotics. There was greater use of antidepressants (23 %), mood stabilizers (19 %), and antianxiety agents (16 %) relative to other studies. The use of anti-impulsives, stimulants and hypnotics was rare (1–2 %). Half of the psychotropics were prescribed for treatment of major psychiatric disorders, 13 % for control of challenging behaviors, and 38 % for both. Results indicated that the major psychiatric disorders, except anxiety disorder and autism, influenced the use of psychotropics and the number of medication used. These findings imply that although practitioners still rely too heavily on the use of antipsychotics in this population, there is a welcome shift in the prescription patterns relative to other studies. The practitioners appeared to use psychotropics primarily to treat diagnosed psychiatric disorders and not just to control aggressive behavior which suggests that evidence-based practice of psychiatry is playing an increasing role in the ID population. En ligne : http://dx.doi.org/10.1007/s10803-012-1617-6 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=192
in Journal of Autism and Developmental Disorders > 43-3 (March 2013) . - p.719-731[article] Prevalence of Psychotropic Drug Use in Adults with Intellectual Disability: Positive and Negative Findings from a Large Scale Study [Texte imprimé et/ou numérique] / John A. TSIOURIS, Auteur ; Soh-Yule KIM, Auteur ; W. Ted BROWN, Auteur ; Jill PETTINGER, Auteur ; Ira L. COHEN, Auteur . - p.719-731.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 43-3 (March 2013) . - p.719-731
Mots-clés : Psychotropics Intellectual disability Survey Diagnosis Challenging behavior Aggression Index. décimale : PER Périodiques Résumé : The use of psychotropics by categories and the reason for their prescription was investigated in a large scale study of 4,069 adults with ID, including those with autism spectrum disorder, in New York State. Similar to other studies it was found that 58 % (2,361/4,069) received one or more psychotropics. Six percent received typical, 6 % received typical, while 39 % received atypical antipsychotics. There was greater use of antidepressants (23 %), mood stabilizers (19 %), and antianxiety agents (16 %) relative to other studies. The use of anti-impulsives, stimulants and hypnotics was rare (1–2 %). Half of the psychotropics were prescribed for treatment of major psychiatric disorders, 13 % for control of challenging behaviors, and 38 % for both. Results indicated that the major psychiatric disorders, except anxiety disorder and autism, influenced the use of psychotropics and the number of medication used. These findings imply that although practitioners still rely too heavily on the use of antipsychotics in this population, there is a welcome shift in the prescription patterns relative to other studies. The practitioners appeared to use psychotropics primarily to treat diagnosed psychiatric disorders and not just to control aggressive behavior which suggests that evidence-based practice of psychiatry is playing an increasing role in the ID population. En ligne : http://dx.doi.org/10.1007/s10803-012-1617-6 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=192 Rates and Predictors of Adherence to Psychotropic Medications in Children with Autism Spectrum Disorders / Sarah L. LOGAN in Journal of Autism and Developmental Disorders, 44-11 (November 2014)
[article]
Titre : Rates and Predictors of Adherence to Psychotropic Medications in Children with Autism Spectrum Disorders Type de document : Texte imprimé et/ou numérique Auteurs : Sarah L. LOGAN, Auteur ; Laura A. CARPENTER, Auteur ; R. Scott LESLIE, Auteur ; Kelly S. HUNT, Auteur ; Elizabeth GARRETT-MAYER, Auteur ; Jane CHARLES, Auteur ; Joyce S. NICHOLAS, Auteur Article en page(s) : p.2931-2948 Langues : Anglais (eng) Mots-clés : Psychotropics Treatment adherence Public health surveillance Autism Index. décimale : PER Périodiques Résumé : Medication adherence in children is poor, particularly among those with chronic or mental health disorders. However, adherence has not been fully assessed in autism spectrum disorders (ASDs). The validated proportion of days covered method was used to quantify adherence to psychotropic medication in Medicaid-eligible children who met diagnostic criteria for ASD between 2000 and 2008 (N = 628). Among children prescribed attention deficit hyperactivity disorder (ADHD) medications, antidepressants, or antipsychotics, 44, 40 and 52 % were adherent respectively. Aggressive behaviors and abnormalities in eating, drinking, and/or sleeping, co-occurring ADHD, and the Medication Regimen Complexity Index were the most significant predictors of adherence rather than demographics or core deficits of ASD. Identifying barriers to adherence in ASD may ultimately lead to improved treatment outcomes. En ligne : http://dx.doi.org/10.1007/s10803-014-2156-0 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=241
in Journal of Autism and Developmental Disorders > 44-11 (November 2014) . - p.2931-2948[article] Rates and Predictors of Adherence to Psychotropic Medications in Children with Autism Spectrum Disorders [Texte imprimé et/ou numérique] / Sarah L. LOGAN, Auteur ; Laura A. CARPENTER, Auteur ; R. Scott LESLIE, Auteur ; Kelly S. HUNT, Auteur ; Elizabeth GARRETT-MAYER, Auteur ; Jane CHARLES, Auteur ; Joyce S. NICHOLAS, Auteur . - p.2931-2948.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 44-11 (November 2014) . - p.2931-2948
Mots-clés : Psychotropics Treatment adherence Public health surveillance Autism Index. décimale : PER Périodiques Résumé : Medication adherence in children is poor, particularly among those with chronic or mental health disorders. However, adherence has not been fully assessed in autism spectrum disorders (ASDs). The validated proportion of days covered method was used to quantify adherence to psychotropic medication in Medicaid-eligible children who met diagnostic criteria for ASD between 2000 and 2008 (N = 628). Among children prescribed attention deficit hyperactivity disorder (ADHD) medications, antidepressants, or antipsychotics, 44, 40 and 52 % were adherent respectively. Aggressive behaviors and abnormalities in eating, drinking, and/or sleeping, co-occurring ADHD, and the Medication Regimen Complexity Index were the most significant predictors of adherence rather than demographics or core deficits of ASD. Identifying barriers to adherence in ASD may ultimately lead to improved treatment outcomes. En ligne : http://dx.doi.org/10.1007/s10803-014-2156-0 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=241